Global /China /Healthcare /Drug Manufacturers - General /688566

Jiangsu Jibeier Pharmaceutical Co., Ltd.

688566

• SSE: 688566 • Delayed

28.00CNY 0.1%

4.14 USD

As of 21 June 2026, Jiangsu Jibeier Pharmaceutical Co., Ltd. has a market cap of $825.17M USD, ranking #11892 globally and #3493 in China. It ranks #1084 in the Healthcare sector, and #405 in the Drug Manufacturers - General industry.

Global Rank

11892

Country Rank

3493

Sector Rank

1084

Industry Rank

405

Key Stats

Market Cap

$825.17MUSD

5.58B CNY

Enterprise Value

$712.91MUSD

4.83B CNY

Revenue (TTM)

$146.6MUSD

990.68M CNY

EBITDA (TTM)

$38.38MUSD

259.82M CNY

Net Income (TTM)

$37.6MUSD

254.07M CNY

EBITDA Margin

26%

Profit Margin

26%

PE Ratio

22.0

PS Ratio

5.6

PB Ratio

2.2

EV/EBITDA

18.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Zhongyi Geng open_in_new

Employees

1,326

Founded

2001

Website

jbepharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.1%	-5.1%	-5.7%	-2.5%	-16%	-6.2%	17%	-5.9%	17%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688566 江苏吉贝尔药业股份有限公司 Class A ISIN: CNE100004041 Shares Out.: Shares Outstanding: 201.102M¹ Shares Float: 201.091M² TV: TradingView: SSE: 688566 SA: Stock Analysis: SHA: 688566 YF: Yahoo Finance: 688566.SS GF: Google Finance: SHA: 688566 BA: Barron's: 688566 MS: Morningstar: XSHG: 688566	28.00 CNY	TV: TradingView: SSE: 688566 SA: Stock Analysis: SHA: 688566 YF: Yahoo Finance: 688566.SS GF: Google Finance: SHA: 688566 BA: Barron's: 688566 MS: Morningstar: XSHG: 688566

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jiangsu Jibeier Pharmaceutical Co., Ltd.

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company’s products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in tablets, capsules, and eye drops forms. Jiangsu Jibeier Pharmaceutical Co., Ltd. was founded in 2001 and is based in Zhenjiang, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$54.0B 364.89B CNY 6K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.78B 336.36B CNY 6K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.51B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.56B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 92K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 66K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 44K%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 38K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 34K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 33K%	15.1	United States

chevron_leftBack